Conceive Fertility and Maternity Centre

1
Conceive Fertility and Maternity Centre
Conceive Fertility and Maternity Center is a
Speciality Center for Infertility and
Laparoscopic Surgeries. The Clinic is gone to by
Dr. Siri. V and Dr. Ashwini. S who have colossal
involvement in treating infertility and in IVF.
They have been Consistently getting a Pregnancy
rate of over half both in new and solidified
developing life exchange cycles, which is keeping
pace with the International standards. The point
which recognizes them from the greater part of
alternate focuses is their own association in
your treatment dealing with every single part of
your treatment cycle.
Dr. Ashwini S is a Gynecologist,Infertility Specia
list and Obstetrician in Rajajinagar, Bangalore
and has an affair of 15 years in these fields.
Dr. Ashwini S
2
hones at NU Hospitals in Rajajinagar,
Bangalore,Conceive Fertility And Maternity
Center in Nagarbhavi, Bangalore and NU Hospitals
in Padmanabhanagar, Bangalore. She finished MBBS
from J.S.S Medical College, Mysore in 2003,DGO
from Bangalore Medical College and Research
Institute, Bangalore in 2007 and DNB -
Obstetrics and Gynecology from HAL Hospital
Bangalore in 2011. She is an individual from
Karnataka Medical Council,Bangalore Society of
Obstetrics and Gynaecology,Indian Medical
Association (IMA),Indian Society for Assisted
Reproduction (ISAR) and Karnataka Chapter Of ISAR
(KISAR). A portion of the administrations gave
by the specialist are Egg Donation,Vaginoplasty,
Tubectomy/Tubal Ligation,Lab Tests and
Dysmenorrhea Treatment and so forth. Dr.
Ashwini S Gynecologist has finished her MBBS from
Government Medical College, Mysore, in 2002. She
at that point chose to seek after her enthusiasm
for Gynecology by getting a Diploma in
Gynecology and Obstetrics (DGO) at Bangalore
Medical College, and then additionally went ahead
to seek after DNB in OBG. Further, she has
effectively finished Fellowship in Reproductive
Medicine from Rajiv Gandhi University of Health
Sciences at Gunasheela IVF Center,
Bangalore. She has additionally experienced
propelled preparing in Endoscopic systems
(Laparoscopic and Hysteroscopic Surgeries). She
represents considerable authority in Infertility
and IVF treatment, Laparoscopic and Hysteroscopic
strategies like indicative laparoscopy, ovarian
boring, reconstructive surgery for endometriosis,
ovarian cystectomies, myomectomies, add up to
laparoscopic hysterectomies, demonstrative and
agent hysteroscopic systems like septal
resection, adhesiolysis, and tubal
cannulation. Dr. Ashwini S is a
Gynecologist,Infertility Specialist and
Obstetrician in Rajajinagar, Bangalore and has
an experience of 14 years in these fields. Dr.
Ashwini S practices at NU Hospitals in
Rajajinagar, Bangalore,Conceive Fertility
Maternity Centre in Nagarbhavi, Bangalore and NU
Hospitals in Padmanabhanagar,
3
Bangalore. She completed MBBS from J.S.S Medical
College, Mysore in 2003,DGO from Bangalore
Medical College and Research Institute, Bangalore
in 2007 and DNB Obstetrics Gynecology from
HAL Hospital Bangalore in 2011. She is a member
of Karnataka Medical Council,Bangalore Society of
Obstetrics Gynaecology,Indian Medical
Association (IMA),Indian Society for Assisted
Reproduction (ISAR) and Karnataka Chapter Of ISAR
(KISAR). Some of the services provided by the
doctor are Normal Vaginal Delivery
(NVD),Contraception Advice,Ultrasound
Scan,Obstetrics Problems and Obstetrics /
Antenatal Care etc. Preimplantation genetic
testing is a technique used to identify genetic
defects in embryos created through in vitro
fertilization (IVF) before pregnancy.
Preimplantation genetic diagnosis (PGD) refers
specifically to when one or both genetic parents
has a known genetic abnormality and testing is
performed on an embryo to determine if it also
carries a genetic abnormality. In contrast,
preimplantation genetic screening (PGS) refers to
techniques where embryos from presumed
chromosomally normal genetic parents are screened
for aneuploidy. Because only unaffected embryos
are transferred to the uterus for implantation,
preimplantation genetic testing provides an
alternative to current postconception diagnostic
procedures (ie, amniocentesis or chorionic villus
sampling), which are frequently followed by the
difficult decision of pregnancy termination if
results are unfavorable. PGD and PGS are
presently the only options available for avoiding
a high risk of having a child affected with a
genetic disease prior to implantation What is
IVF and PGD? Preimplantation genetic diagnosis
(PGD) is a screening test used to determine if
genetic or chromosomal disorders are present in
embryos produced through in vitro fertilization
(IVF). PGD screens embryos before they are
transferred to the uterus so couples can make
informed decisions about their next steps in the
IVF process. Embryos unaffected by the genetic
or chromosomal disorder can be selected for
transfer to the uterus.
4
For couples undergoing IVF, PGD may be
recommended when One or both partners has a
history of heritable genetic disorders One or
both partners is a carrier of a chromosomal
abnormality The mother is of advanced maternal
age The mother has a history of recurrent
miscarriages Thousands of clinical PGD cycles
have been performed worldwide, resulting in the
birth of hundreds of healthy babies. PGD does
not replace prenatal testing, such as chorionic
villus sampling or amniocentesis. It provides
diagnostic information based on the analysis of a
single cell, so prenatal testing is still
recommended and currently remains the standard
of care. In This Section Treatments and
Procedures Learn the step-by-step process for
identifying genetic or chromosomal disorders in
embryos via preimplantation genetic
diagnosis. Related Programs Services Women's
Health Fertility Care Male Infertility PCOS
Program Reproductive Surgery Assisted
Reproduction/In Vitro Fertilization Third-Party
Reproduction Pre-implantation genetic diagnosis
(PGD) is generally defined as the testing of
pre-implantation stage embryos or oocytes for
genetic defects. It has been developed for
couples whose potential offspring are at risk of
severe Mendelian disorders, structural
chromosome abnormalities or mitochondrial
disorders. Pre-implantation embryo diagnosis
requires in vitro fertilization, embryo biopsy
5
and either using fluorescent in situ
hybridization or polymerase chain reaction at
the single cell level. Therefore, it is a complex
procedure which requires much experience.
Aneuploidy screening to improve medically
assisted reproduction (in vitro
fertilization/intracytoplasmic sperm injection)
is a variant type of PGD. The past, present and
future of this development are strongly related
to the natural occurrence of chromosomal
mosaicism in the pre-implantation embryo. PGD
should be included in each reproductive health
care programme. It is recognized as an important
alternative to pre-natal diagnosis. However,
diagnosis from a single cell remains a
technically challenging procedure, and the risk
of misdiagnosis cannot be eliminated. An ethical
discussion of the question of whether PGD is
acceptable at all-the 'desirability question'-is
a rearguard action. Discussion must primarily
focus on the conditions of exercising due caution
in and the dynamics of PGD. WHAT IS
PREIMPLANTATON GENETIC DIAGNOSIS? PGD is a
technique that enables couples with a particular
inherited condition in their family to avoid
passing it on to their children. The process
helps potential parents prevent the birth of a
child with a serious genetic condition. PGD is
used when a couple has a known risk of passing
on a genetic abnormality and diagnostic testing
is performed on an embryo to determine if it has
also inherited the abnormality. PGD involves
the use of assisted reproductive technology
(ART). Eggs are obtained and fertilised through
in vitro fertilisation (IVF). Once fertilised,
the embryos develop for 5-6 days and then a
number of cells are removed from each embryo.
The genetic material (DNA or chromosomes) within
these cells of the embryo is then tested for the
genetic or chromosomal abnormality. An unaffected
embryo is then transferred to the womans uterus
to implant. If successful, the procedure will
result in pregnancy and the child should not be
affected by the condition for which it was
tested.
6
WHO CAN USE PREIMPLANTATION GENETIC
DIAGNOSIS? Couples who request PGD are at risk of
passing on a serious genetic condition to their
children. Parents may have the condition
themselves or be carriers of the condition. They
may already have a child affected or they may
have experienced the loss of a child or
pregnancy affected with the condition. Couples
generally considered for PGD include Carriers
of a serious autosomal recessive condition For
carriers of an autosomal recessive condition,
there is a 1 in 4 (25) risk of each pregnancy
delivering an affected child. Carriers of a
serious autosomal dominant condition For
carriers of an autosomal dominant condition,
there is a 1 in 2 (50) risk of each pregnancy
delivering an affected child. Couples with
inherited chromosome disorders. Couples with a
family history of serious sex-linked disorders
Couples with a family history of a sex-linked
disorder have a 1 in 4 (25) risk of each
pregnancy delivering an affected child (half of
all male children). Therefore, PGD may be
recommended if you or your partner has a family
history of a serious genetic condition and/or you
and your partner already have a child with a
serious genetic condition and/or you and your
partner have had a number of pregnancy
terminations because your baby had a serious
genetic condition. In this section we have used
the word serious a lot. This is because the
HFEA must find that a condition is sufficiently
serious to allow PGD in relation to it. For
More Information You Can Contact Us
7
Block 30, East Patel Nagar, Rajendra Place, New
Delhi, Delhi 110008 (91)-7899912611 contact_at_elawo
man.com https//www.elawoman.com/ Contact Form
Ela Facebook
Ela Twitter
Ela Instagram
Ela Linkedin
Ela Youtube